The IRE1α Endonuclease Plays a Dual Role in Regulating the XBP1/miRNA-34a Axis and PD-1 Expression within Natural Killer Cells in Hodgkin Lymphoma
Acta Haematologica · 2024
DOI: 10.1159/000536044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Haematologica, 2024. Verfasst von Karolina Bednarska und 12 weiteren Autor:innen. Beteiligte Einrichtung: Mater Research Institute, University of Queensland, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Killer Cells, Natural, MicroRNAs, Hodgkin Disease, X-Box Binding Protein 1. Die Arbeit nennt 51 Literaturangaben.
Abstract (Originalsprache)
Introduction
Hodgkin lymphoma (HL) is deficient in major histocompatibility complex class I, rendering it susceptible to antitumoral immunity by natural killer (NK) cells. Despite the functional impairment of PD-1+ NK cells in HL, the underlying mechanisms of NK cell dysfunction remain unclear.
Methods
This study involved 14 HL patients and SNK10/KHYG-1 cell lines to assess NK cell activation against cancer cells. Activation was measured through transcript (PCR) and protein expression (flow cytometry). Regulatory mechanisms associated with IRE1α activation were validated through knockdown and luciferase reporter assays.
Results
Our findings reveal a novel role for IRE1α-endonuclease in fine-tuning NK cell effector functions by orchestrating the XBP1s/microRNA-34a-5p/PD-1 axis. When NK cells encounter cancer cells, IRE1α endonuclease activates the decay of microRNA-34a-5p, resulting in increased expression of XBP1s and PD-1. IRE1α-endonuclease activation enhances NK cell functions while promoting PD-1 expression. In turn, PD-1 is directly regulated by microRNA-34a-5p, which binds to the 3′UTR of PD-1 transcript to repress PD-1 protein on the NK cell surface. Importantly, IRE1α-pathway activation is impaired in NK cells from HL patients.
Conclusion
The IRE1α endonuclease emerges as a key player, simultaneously regulating the XBP1s/microRNA-34a-5p/PD-1 axis in NK cells, a process disrupted in HL. Targeting the IRE1α-pathway holds promise as a therapeutic strategy to optimize NK cell functions in Hodgkin lymphoma treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mater Research Institute, University of Queensland, Brisbane, Queensland, Australia.
- Frazer Institute, University of Queensland, Brisbane, Queensland, Australia.
- Griffith Institute for Drug Discovery, Griffith University, Brisbane, Queensland, Australia.
- Haematology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Zitieren
APA
Bednarska, K., Thillaiyampalam, G., Mujaj, S., Nourse, J., Gunawardana, J., Sabdia, M. B., Law, S. C., Pilaar, A., Cui, Q., de Long, L. M., Vari, F., Gandhi, M. K., & Cristino, A. S. (2024). The IRE1α Endonuclease Plays a Dual Role in Regulating the XBP1/miRNA-34a Axis and PD-1 Expression within Natural Killer Cells in Hodgkin Lymphoma. Acta Haematologica. https://doi.org/10.1159/000536044
Vancouver
Bednarska K, Thillaiyampalam G, Mujaj S, Nourse J, Gunawardana J, Sabdia MB, et al. The IRE1α Endonuclease Plays a Dual Role in Regulating the XBP1/miRNA-34a Axis and PD-1 Expression within Natural Killer Cells in Hodgkin Lymphoma. Acta Haematologica. 2024. doi:10.1159/000536044
BibTeX
@article{Bednarska2024,
author = {Bednarska, Karolina and Thillaiyampalam, Gayathri and Mujaj, Sally and Nourse, Jamie and Gunawardana, Jay and Sabdia, Muhammed B and Law, Soi C and Pilaar, Anna and Cui, Qingyan and de Long, Lilia M and Vari, Frank and Gandhi, Maher K and Cristino, Alexandre S},
title = {The IRE1α Endonuclease Plays a Dual Role in Regulating the XBP1/miRNA-34a Axis and PD-1 Expression within Natural Killer Cells in Hodgkin Lymphoma},
journal = {Acta Haematologica},
year = {2024},
doi = {10.1159/000536044}
}
EUVIMED